Journal of Cancer Research and Therapeutics Close
 

Figure 4: Immunostaining of KB-cells with fascin and Ki-67 proteins (magnifi cation ×400). (A) Strong immunoreaction to fascin in RPMI. (B) KB-cells after doxorubicin-treatment. (C) Strong reactivity to Ki-67 before doxorubicin treatment. (D) Strong reactivity to Ki-67 after doxorubicin treatment. No immunostaining is noticeable in E (negative control)

Figure 4: Immunostaining of KB-cells with fascin and Ki-67 proteins (magnifi cation ×400). (A) Strong immunoreaction to fascin in RPMI. (B) KB-cells after doxorubicin-treatment. (C) Strong reactivity to Ki-67 before doxorubicin treatment. (D) Strong reactivity to Ki-67 after doxorubicin treatment. No immunostaining is noticeable in E (negative control)